| 000 | 01787 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515010110.0 | ||
| 264 | 0 | _c20061213 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a1545-5009 | ||
| 024 | 7 |
_a10.1002/pbc.20685 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFreeman, Burgess B | |
| 245 | 0 | 0 |
_aPharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancer. _h[electronic resource] |
| 260 |
_bPediatric blood & cancer _cOct 2006 |
||
| 300 |
_a572-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChondrosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoietin _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematinics _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHinds, Pamela | |
| 700 | 1 | _aIacono, Lisa C | |
| 700 | 1 | _aRazzouk, Bassem I | |
| 700 | 1 | _aBurghen, Elizabeth | |
| 700 | 1 | _aStewart, Clinton F | |
| 773 | 0 |
_tPediatric blood & cancer _gvol. 47 _gno. 5 _gp. 572-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.20685 _zAvailable from publisher's website |
| 999 |
_c15940299 _d15940299 |
||